# Alzchem Group invests EUR 120M in creatine production facility in Trostberg

Alzchem Group AG adopted a comprehensive investment program of around EUR 120 million for further capacity expansion in creatine products. The investment will go into a new, increasingly automated production facility for creatine and its precursors, as well as upstream infrastructure, with commissioning planned in stages starting in the second half of 2027.

- Type: Investment
- Announced: 2025-12-04
- Where: Trostberg, Germany, Germany
- Value: $126.0M (120.0M EUR)
- Starts operating: Q3 2027
- Status: announced
- Products: creatine and its precursors
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [AlzChem Group AG](https://endata.com/companies/50995.md)

## Sources

- [alzchem.com](https://www.alzchem.com/en/company/news/investment-program-worth-around-eur-120-million/), 2025-12-04: "A total of around EUR 120 million is to be invested in the construction of a new, increasingly automated production facility for creatine and its precursors, as well as in the upstream infrastructure."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.